---
figid: PMC6160678__jcav09p3382g006
figtitle: An comprehesive metabolomics and transcriptomics study to identify metabolic
  pathway alterations in CFG treatment of ovarian tumor-bearing mice in vivo
organisms:
- Homo sapiens
- Mus musculus
- Bos taurus
- Venustaconcha ellipsiformis
organisms_ner:
- Homo sapiens
- Bos taurus
- Mus musculus
- Danio rerio
pmcid: PMC6160678
filename: jcav09p3382g006.jpg
figlink: /pmc/articles/PMC6160678/figure/F6/
number: F6
caption: An comprehesive metabolomics and transcriptomics study to identify metabolic
  pathway alterations in CFG treatment of ovarian tumor-bearing mice in vivo. (A)
  Integrative co-analysis of metabolomics and transcriptomics. Significance was determined
  as p<0.05. (B) Pathway illustration of galactose metabolism. (C) Pathway illustration
  of fatty acid elongation, oxidation and metabolism. (D) A Schematic to show the
  differential metabolic pathways involved in CFG treatment of ovarian cancer.
papertitle: Compound Fuling Granule Suppresses Ovarian Cancer Development and Progression
  by disrupting mitochondrial function, galactose and fatty acid metabolism.
reftext: Shanming Ruan, et al. J Cancer. 2018;9(18):3382-3393.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5598739
figid_alias: PMC6160678__F6
figtype: Figure
redirect_from: /figures/PMC6160678__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6160678__jcav09p3382g006.html
  '@type': Dataset
  description: An comprehesive metabolomics and transcriptomics study to identify
    metabolic pathway alterations in CFG treatment of ovarian tumor-bearing mice in
    vivo. (A) Integrative co-analysis of metabolomics and transcriptomics. Significance
    was determined as p<0.05. (B) Pathway illustration of galactose metabolism. (C)
    Pathway illustration of fatty acid elongation, oxidation and metabolism. (D) A
    Schematic to show the differential metabolic pathways involved in CFG treatment
    of ovarian cancer.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CYP2B6
  - MUC5AC
  - G6PC1
  - GALM
  - LALBA
  - B4GALT1
  - ACADL
  - UGP2
  - SCD
  - SCD5
  - ACADS
  - MUC1
  - DMBT1
  - G6pc1
  - Lalba
  - B4galt1
  - Acadl
  - Ugp2
  - Scd1
  - Acads
  - g6pc1a.1
  - b4galt1
  - acadl
  - ugp2b
  - scd
  - acads
  - Glucose
  - Ascorbate
  - Phosphate
  - Porphyrin
  - chlorophyll
  - sucrose
  - glucuronate
  - Retinol
  - unsaturated fatty acids
  - Pentose phosphate
  - Fatty acid
  - Galactose
  - Histidine
  - Alanine
  - Fructose
  - mannose
  - Phenylalanine
  - Glycine
  - serine
  - threonine
  - D-Glucose
  - 1-phosphate 1-phosphate
  - Uridine
  - diphosphate glucose
  - diphosphategalactose
  - Pyrophosphate
  - 5-monaphosphate
  - Lactose
  - Adenosine
  - 5-dipiosphate
  - 1-phosphate
  - friphosphate
  - Phosphoric acid
  - diphosphate
  - OAdenosine
  - 5-diphosphate
  - Caproic
  - Coenzyme A
  - Fatty Acid
  - neonaphosphate
  - OPyroghosphate
  - ISHydroyteanoyl-CoA
  - 3ydanbutyry-CoA
  - Cancer
  - tumor
  - CHSI
---
